Antineutrophil cytoplasmic antibody (ANCA)-associated autoimmune disease induced by propylthiouracil;Auto-imunidade ANCA (anticorpo anti-citoplasma de neutrófilos) positiva induzida por propiltiouracil: Relato de caso e revisão da literatura

Arquivos Brasileiros de Endocrinologia e Metabologia

Volumn 51, Issue 1, 2007, Pages 136-141

  Pietszkowski, Nádila Cecyn ^a   De Carvalho, Gisah Amaral ^a   De Souza, Hevelyn Noemberg ^a   Werka Jr , Cláudio Rogério ^a   Borazo, Luís Augusto ^a   Graf, Hans ^a   De Carvalho, Mauricio ^a,b  

^a FEDERAL UNIVERSITY OF PARANÁ   (Brazil)

^b Serviço de Endocrinologia e Metabologia   (Brazil)

Author keywords

ANCA; Propylthiouracil; Vasculitis

Indexed keywords

ANTITHYROID AGENT; IMMUNOLOGIC FACTOR; NEUTROPHIL CYTOPLASMIC ANTIBODY; PEROXIDASE; PROPYLTHIOURACIL;

ADULT; ARTICLE; AUTOIMMUNE DISEASE; BLOOD; CASE REPORT; CHEMICALLY INDUCED DISORDER; FEMALE; GRAVES DISEASE; HUMAN; IMMUNOLOGY; VASCULITIS;

ADULT; ANTIBODIES, ANTINEUTROPHIL CYTOPLASMIC; ANTITHYROID AGENTS; AUTOIMMUNE DISEASES; FEMALE; GRAVES DISEASE; HUMANS; IMMUNOLOGIC FACTORS; PEROXIDASE; PROPYLTHIOURACIL; VASCULITIS;

EID: 34247139345     PISSN: 00042730     EISSN: 16779487     Source Type: Journal    
DOI: 10.1590/S0004-27302007000100022     Document Type: Article

References (31)

1. Sato H, Hattori M, Fujieda M, Sugihara A, Inomata H, Hoshi M, et al. High prevalence of antineutrophil cytoplasmic antibody positivity in childhood onset Graves' disease treated with propylthiouracil. J Clin Endocrinol Metab 2000;85:4270-3.
2. Gaburri PD, Chebli JMF, Attalla A, Pereira CMN, Bonfante HL, Martins-junior EV, et al. Colonic ulcers in propylthiouracil induced vasculitis with secondary antiphospholipid syndrome. Postgrad Med J 2005;81:338-40.
3. Slot M, Links TP, Stegeman CA, Tervaert JWC. Occurrence of antineutrophil cytoplasmic antibodies and associated vasculitis in patients with hyperthyroidism treated with antithyroid drugs: a long-term follow-up study. Arthritis Rheum 2005;53:108-13.
4. Choi HK, Merkel PA, Walker AM, Niles JL. Drug associated antineutrophil cytoplasmic antibody positive vasculitis: prevalence among patients with high titers of antimyeloperoxidase antibodies. Arthritis Rheum 2000;43:405-13.
5. Vanek C, Samuels MH. Central nervous system vasculitis caused by propylthiouracil therapy: a case report and literature review. Thyroid 2005;15:80-4.
6. Bonaci-Nikolic B, Nikolic MM, Andrejevic S, Zoric S, Bikilica M. Antineutrophil cytoplasmic antibody (ANCA)-associated autoimmune diseases induced by antithyroid drugs: comparison with idiopathic ANCA vasculitides. Arthritis Res Ther 2005;7:1072-81.
7. Gao Y, Ye H, Yu F, Guo X-H, Zhao M-H. Anti-myeloperoxidase IgG subclass distribution and avidity in sera from patients with propylthiouracil-induced antineutrophil cytoplasmic antibodies vasculitis. Clin Immunology 2005;117:87-93.
8. Guma M, Salina S, Reverter JL, Roca J, Valls-Roc M, Juan M, et al. Frequency of antineutrophil cytoplasmic antibody in Graves' disease patients treated with methimazole. J Clin Endocrinol 2003;88:3141-6.
9. Morita S, Ueda Y, Eguchi K. Anti-thyroid drug induced ANCA associated vasculitis: a case report and review of the literature. Endocr J 2000;47:467-70.
10. Thamprajamchit S, Jariengprasert C, Rajatanavin R. Propylthiouracil- induced sensorineural hearing loss associated with antineutrophil cytoplasmic antibodies. Endocr Pract 2004;10:432-7.
11. Gunton JE, Stiel J, Caterson RJ, McElduff A. Anti-thyroid drugs and antineutrophil cytoplasmic antibody positive vasculitis. A case report and review of the literature. J Clin Endocrinol Metab 1999;84:13-6.
12. Dhillon SS, Singh D, Doe N, Qadri AM, Ricciardi S, Schwarz MI. Diffuse alveolar hemorrhage and pulmonary capillaritis due to propylthiouracil. Chest 1999;116:1485-8.
13. Tsai MH, Chang YL, Wu VC, Chang CC, Huang TS. Methimazole induced pulmonary hemorrhage associated with antimyeloperoxidase antineutrophil cytoplasmic autoantibody: a case report. J Formos Med Assoc 2001;100:772-5.
14. Yamauchi K, Sata M, Machiya J, Osaka D, Wada T, Abe S, et al. Antineutrophil cytoplasmic autoantibody positive alveolar hemorrhage during propylthiouracil therapy for hyperthyroidism. Respirology 2003;8:532-5.
15. Ohwada R, Kato K, Ohmori K, Isosaki O, Hotta M, Ono M, et al. A man with interstitial pneumonia due to propylthiouracil. Inter Med 2003;42:1026-30.
16. Nakamoro Y, Tominaga T, Inoue Y, Shinohara K. Propylthiouracil induced associated with antineutrophil antibody against myeloperoxidase. Inter Med 2003;42:463-4.
17. Vazel-Boulenger A, Kupfer-Bessaguet I, Gouedard C, Leberre R, Leroy JP, Sonnet E, et al. Neutrophilic dermatosis associated with propylthiouracil- induced p-ANCA. Ann Dermatol Venereolol 2005;132:27-31.
18. Jacobs EM, Hartkemp A, Kaasjager HA. PTU associated cutaneus vasculitis with ANCA anti-MPO and anti PR3 antibodies. Neth J Med 2003;61:296-9.
19. Hong SB, Lee MH. A case of propylthiouracil induced pyoderma gangrenosum associated with antineutrophil cytoplasmic autoantibody. Dermatology 2004;208:339-41.
20. Kudoh Y, Kuroda S, Shimamoto K, Iimura O. Propylthiouracil induced rapidly progressive glomerulonephritis associated with antineutrophil cytoplasmic antibodies. Clin Nephrol 1997;48:41-3.
21. Kitara T, Hiromura K, Maezawa A, Ono K, Narabara N, Yano S, et al. Case of propylthiouracil induced vasculitis associated with antineutrophil cytoplasmic antibodies; review of literature. Clin Neprhol 1997;47:336-40.
22. Winters MJ, Hurley RM, Lirenman DS. ANCA positive glomerulonephritis and IgA nephropathy in a patient on propylthiouracil. Pediatr Nephrol 2002;17:257-60.
23. Yamada A, Sato K, Tochimoto A, Takagi S, Hizuka N, Takano K. Propylthiouracil induced lupus-like syndrome developing in a Graves patient with a sibling with systemic lupus erytematosus. Intern Med 2002;41:1204-8.
24. Ye H, Guo X-H, Zhao M-H, Gao Y, Zhang Y, Gao Y. Epitope mapping of myeloperoxidades antibodies in propylthiouracil-induced vasculitis and microscopic polyangiitis. Zhonghua Nei Ke ZA ZHI 2004;43:915-9.
25. Noh JY, Asari T, Hamada N, Ishikawa N, Abes H, Ito K. Frequency of appearance of myeloperoxidades-antineutrophil cytoplasmic antibodies (MPO-ANCA) in Graves's disease patients treated with propylthiouracil and the relationship between MPO-ANCA and clinical manifestations. Clin Endocrinol 2001;54:651-4.
26. Yu F, Zhao Mh, Zhang YK, Zhang Y, Wang HY. Anti-endothelial cell antibodies with propylthiouracil-induced ANCA positive vasculitis are associated with disease activity. Clin Exp Immunol 2005;139:569-74.
27. Gunton JE, Clifton-Bligh P, Wilmshurst E, McEldulff A. Prevalence of antineutrophil cytoplasmic antibody in patients receiving antithyroid medication. Eur J Endocrinol 2000;142:587-90.
28. Fujieda M, Hatori M, Kurayama H. Clinical features and outcomes with antineutrophil cytoplasmic auto antibody positive glomerulonephritis with on propylthiouracil treatment. J Am Soc Nephrol 2002;13:437-45.
29. Sera N, Ashizawa K, Ando T, Abe Y, Ide A, Usa T, et al. Treatment with propylthiouracil is associated with appearance of antineutrophil cytoplasmic antibodies in some patients with Graves disease. Thyroid 2000;10:595-9.
30. Harper L, Chin L, Daykin J, Allahabadia A, Heward J, Gough C, et al. Propylthiouracil and carbimazole associated antineutrophil cytoplasmic antibodies in Patients with Graves's disease. Clin Endocrinol 2004;60:671-5.
31. Wada N, Mukai M, Kohno M, Notoya A, Ito T, Yoshioka N. Prevalence of serum anti-myeloperoxidades antineutrophil cytoplasmic antibodies in patients with Graves's disease treated with propylthiouracil and thiamazole. Endocr J 2002;49:329-34.